Skip to main navigation Skip to search Skip to main content

Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015–2019: the RECUR Germany study

  • Ana Antunes
  • , Aurore Tricotel
  • , Adrian Wilk
  • , Silvia Dombrowski
  • , Hanna Rinta-Kokko
  • , Fredrik L. Andersson
  • , Subrata Ghosh
  • IQVIA Portugal
  • IQVIA Inc.
  • Team Gesundheit GmbH
  • IQVIA Finland
  • Ferring Pharmaceuticals

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015–2019: the RECUR Germany study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science